About us
to multiply you must be able to divide
Our Vision
Our VISION is to bring the versatile, robust and low cost G2 technology to the market and thereby to promote recycling and upcycling of biomass and textile waste, combined with an attractive business case
Our Strategy
Our STRATEGY is to speed up the implementation of our G2 technology in the market by finding and hooking up with suitable strategic partner(s), capable to exploit the overall G2 technology platform fast and to the fullest
OUR BUSINESS PLAN
To achieve our strategy, we will demonstrate the technical and economic benefits of our G2 technology in a limited number of high quality/high value product applications
Management team
- 28+ years experience in chemical industry
- Former CEO at Black Bear Carbon
- Former COO at Avantium
- MBA from IESE Business School
- MSc in Chemical Engineering from University of Twente, MSc in Mechanical Engineering from Delft University
- 25+ years experience in the chemical industry
- Former technology manager sustainable chemistry at BP, former strategy advisor at BP
- Former technical manager at INEOS, commercializing PET recycling
- PhD degree in Chemistry from the University of Amsterdam
- 20+ years experience in product development for fibers, textile, coatings and membranes
- Sr. Research and Innovation management roles at Teijin Aramid and various start-ups
- PhD & MSc degree in Chemical Engineering from University of Twente
Founding team
- Innovator & entrepreneur in the Renewables, CO₂ reduction and Bio-fuels and Bio-materials space.
- Executive roles in R&D, technology and business development at Shell, AkzoNobel, and Albemarle.
- Science & Technology advisor at Climeworks AG.
- Inventor of a significant number of patents in the area of catalysis, biomass conversion, CO₂ reduction and the synthesis and application of advanced materials.
- Co-inventor of the ZnCl2 based G1 and G2 technology, including recent developments to produce nanocellulose and lignin.
- Founding partner of several green-tech companies: BIOeCON, KiOR, BiCHEM, ANTECY, CELLiCON.
- PhD chemist with a background in chemistry, physics, catalysis and biochemicals & -oils.
- Director and executive roles in R&D and business development at AkzoNobel, Albemarle, BIOeCON, KiOR and BiCHEM.
- Numerous publications and patents in the area of crystallography, catalysis and biomass conversion.
- Managing director at BiCHEM where the ZnCl2 technology was scaled up .
- Co-inventor of the ZnCl2 technology, including recent developments to produce nanocellulose and lignin.
- Senior executive, international experience in managing the strategy and performance of global businesses in specialty chemicals (bio-chem & -medical).
- Specialty: transforming new technologies into unique value and business propositions. Built a portfolio >$1 billion of new and adjacent businesses, including JV’s and acquisitions.
- Key player in development & commercialization of new products at Philips, DSM, Lubrizol, Purac/Corbion and StoraEnso (senior VP innovation bio-materials).
- Responsible for PLA technology development and Commercialization at Purac/Corbion.
- Seasoned global business leader and chemical industrialist with senior Executive Roles in Dow Chemical (USA), AKZONOBEL (Europe) and Teijin Ltd (Japan).
- Chairman of the advisory platform to the Dutch government to formulate and progress the Bio-Based-Economy objectives
- Program director of Masters in Alternative Energy at University of Delft.
- Founding shareholder and supervisory positions in several companies and start-ups.
From BIOeCON (2005) to CELLiCON (Today)
Our History
• 2005: BIOeCON Founded with vision to convert waste biomass into fuels & chemicals via low cost non-enzymatic catalysis
• 2007: First inventions in the area of bio-catalytic cracking and selective solvent for biomass dissolution and conversion (G1 technology)
• Two separate ventures started: KiOR (2007) and BiCHEM (2009), a JDA with Petrobras. Both ventures eventually discontinued for operational/political reasons. BIOeCON retains IP on ZnCl₂ technology and starts development of G2 technology
• 2017: Strategic shift from chemicals to materials. New company CELLiCON founded
• 2018: CELLiCON licenses BIOeCON’s G2 technology and acquires majority of shares in BIOeCON.
• 2019: CELLiCON files patent on improved and expanded G2 technology.
• 2019-2022: CELLiCON further improves G2 technology and expands product portfolio
• 2022: Sulzer acquires stake in CELLiCON
• 2023: CELLiCON strongly expands team, while recovering from the tragic loss of two of its co-founders
• 2023: CELLiCON is relocated to a brand new lab facility in Arnhem
• 2024 CELLiCON becomes partner of CPNL program "TEXPOWER" to scale its G2 technology for the separation of polycotton into polyester and cellulose
• 2024 CELLiCON presents its G2 technology at the Innovation Days of the Dornbirn Global Fiber Conference
• 2025 New Management Team appointed to scale the G2 technology
